![Kevin Parker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Parker
Chief Executive Officer at Cartography Biosciences, Inc.
Network origin in Kevin Parker first degree
Entity | Entity type | Industry | |
---|---|---|---|
Cartography Biosciences, Inc.
![]() Cartography Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cartography Biosciences, Inc. is a biotech company that specializes in developing tumor-selective therapeutics using a unique genomics and computational platform. The company is based in Foster City, CA. The company integrates data from proprietary sample sourcing relationships, a comprehensive reference atlas, and target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography Biosciences is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. The company was founded by Ansuman Satpathy, Howard Y. Chang, Kevin Parker. Kevin Parker has been the CEO since incorporation.
2
| Holding Company | Pharmaceuticals: Other | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kevin Parker via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Sheppard, Mullin, Richter & Hampton LLP
![]() Sheppard, Mullin, Richter & Hampton LLP Miscellaneous Commercial ServicesCommercial Services Sheppard, Mullin, Richter & Hampton LLP provides legal services. It offers legal expertise and counsel to U.S. and international clients in a range of practice areas including antitrust, corporate and securities, entertainment, media and communications, finance, and white collar defense. The company was founded in 1927 and it is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
New York University | College/University | Graduate Degree | |
Oral Roberts University | College/University | Undergraduate Degree | |
Eight Enterprises LLC
![]() Eight Enterprises LLC Investment ManagersFinance Eight Enterprises LLC (8VC) is a private equity/venture capital firm founded in 2015 by Joseph T. Lonsdale. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Analyst | |
Appia Bio, Inc.
![]() Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member |
Statistics
International
United States | 9 |
Sectoral
Commercial Services | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Administrative Officer | 2 |
General Counsel | 2 |
Director/Board Member | 2 |
Corporate Secretary | 1 |
Most connected contacts
Insiders | |
---|---|
Blaine Templeman | 7 |
David Moskowitz | 3 |
- Stock Market
- Insiders
- Kevin Parker
- Company connections